Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 17.22B P/E 25.46 EPS this Y -1.30% Ern Qtrly Grth -5.20%
Income 595.69M Forward P/E 21.58 EPS next Y 9.50% 50D Avg Chg 9.00%
Sales 2.88B PEG 5.50 EPS past 5Y 8.49% 200D Avg Chg -4.00%
Dividend N/A Price/Book 22.34 EPS next 5Y 5.62% 52W High Chg -18.00%
Recommedations 2.90 Quick Ratio 1.23 Shares Outstanding 59.36M 52W Low Chg 18.00%
Insider Own 0.06% ROA 11.17% Shares Float 59.20M Beta 0.96
Inst Own 98.16% ROE 54.57% Shares Shorted/Prior 2.75M/2.82M Price 291.77
Gross Margin 59.68% Profit Margin 20.71% Avg. Volume 632,741 Target Price 342.55
Oper. Margin 26.70% Earnings Date Nov 5 Volume 1,400,324 Change 6.33%
About Waters Corporation

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation News
09:49 AM Elf Beauty says short-seller report is 'without merit', analysts defend
11/20/24 Waters Corporation to Present at the Evercore 2024 HealthCONx Conference
11/15/24 What Contributed To The Performance Of Waters Corporation (WAT) In Q3?
11/14/24 Waters Corporation (WAT) Surged on Improved Demand
11/14/24 Should You Invest in the First Trust Water ETF (FIW)?
11/13/24 Waters Corporation Opens State-of-the-Art Precision Manufacturing Facility in Longbridge, UK
11/07/24 Waters New Software Delivers Lab-Centric Business Intelligence and Enables Confident Audit-Readiness
11/04/24 Waters Stock Gains on Earnings & Sales Beat in Q3, Raised View
11/04/24 Waters Corporation Shakes Up Life Sciences Market with 20% Stock Surge
11/02/24 Waters Third Quarter 2024 Earnings: Beats Expectations
11/02/24 Waters Corp (WAT) Q3 2024 Earnings Call Highlights: Strong Revenue and Margin Performance Amid ...
11/02/24 Q3 2024 Waters Corp Earnings Call
11/02/24 Decoding Waters Corp (WAT): A Strategic SWOT Insight
11/01/24 S&P 500 Gains and Losses Today: Waters Stock Surges as Sales Improve
11/01/24 Waters Stock Leads S&P 500 Gains Friday as Earnings Top Estimates
11/01/24 Waters: Q3 Earnings Snapshot
11/01/24 Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results
10/24/24 Estimating The Fair Value Of Waters Corporation (NYSE:WAT)
10/13/24 Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
10/08/24 New Waters Discovery Core Rheometer Brings the Power of Rheology to Routine Quality Control Testing
WAT Chatroom

User Image JFDI Posted - 18 hours ago

$NET gonna send that hundo or $WAT ?

User Image anachartanalyst Posted - 2 weeks ago

https://anachart.com/market-update/november-5th-2024/ $CHTR $W $WAT

User Image MasonCo Posted - 2 weeks ago

$QMMM $WAT MYNZ +10.91% PM LFG, unusually high volume activity last week, apx 30% more than average. 👇😘🚀 This stock may see the last time this price per share PT $5+ 🚀 HUGE PRs drop incoming before the Nov 13 meeting, so compliance is coming—no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead.

User Image KCclean Posted - 2 weeks ago

$WAT gap & go !

User Image Wigglyick Posted - 2 weeks ago

$WAT ER pop - breaking the script in a good way ! Specialized test & measurements equip. No position.

User Image quambi Posted - 2 weeks ago

$WAT $400 next week?

User Image Trading_Angels Posted - 2 weeks ago

$WAT green circle, a good entry point, technically. But low volume. Wait for volume to confirm the next leg up and that buyers are in control again.

User Image thetechtrader Posted - 2 weeks ago

$WAT popped 24.50 to 347.50, gapped up, spiked 30, formed rising flag, extended, tagged 355 +32.75, spiked, tagged 366.79 +42.50. Extension targets are 357 & 365. Support 342-44. #technicaltrading #daytrade #tradealert #marketrecap #stockstowatch #stockstobuy

User Image safeway Posted - 2 weeks ago

$WAT $IONQ further will very strong company.

User Image spdandpwr Posted - 2 weeks ago

$AWK what a slug... $WAT was on my watchlist and I decided to buy this instead. smh

User Image jParkz Posted - 2 weeks ago

$WAT News Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results https://marketwirenews.com/news-releases/waters-corporation-nyse-wat-reports-third-quarter-20-4719063881344583.html $WAT

User Image Petethewiz Posted - 2 weeks ago

$WAT thanks for the profit on that 360 call bought 370 puts now for the election fade

User Image Malahyde Posted - 2 weeks ago

$WAT someone was big short

User Image MakingDreamsReality Posted - 2 weeks ago

PM mOOvers 👀 $COCH -Envoy Medical Gains FDA Approval To Begin Pivotal Study For Acclaim Fully Implanted Cochlear Implant, Offering New Option For Hearing Loss Patients With Innovative Sensor Technology $AMZN -Amazon GAAP EPS of $1.43 beats by $0.29, revenue of $158.88B beats by $1.6B $TILE -Interface Q3 2024 Adj. EPS $0.48 Beats $0.34 Estimate, Sales $344.270M Beat $336.419M Estimate $WAT -Waters Non-GAAP EPS of $2.93 beats by $0.25, revenue of $740M beats by $26.82M $PRLB -Proto Labs Q3 2024 Adj EPS $0.47 Beats $0.32 Estimate, Sales $125.62M Beat $121.38M Estimate

User Image OpenOutcrier Posted - 2 weeks ago

$WAT (+9.0% pre) Waters Corporation (NYSE: WAT) Reports Third Quarter 2024 Financial Results https://finance.yahoo.com/news/waters-corporation-nyse-wat-reports-100000612.html

User Image Elfy Posted - 2 weeks ago

$wat nice swing. I am out for now.

User Image DonCorleone77 Posted - 2 weeks ago

$WAT Waters raises FY24 EPS view to $11.67-$11.87 from $11.55-$11.65 Consensus $11.60. Raises FY24 revenue view to down 0.2%-0.8% from down 0.5%-2%, consensus $2.91B. The company said, "The Company is raising its full-year 2024 sales guidance, and now expects organic constant currency sales growth to be in the range of -0.9% to -0.3%. Currency translation is expected to decrease full-year sales growth by 1.2%. M&A contribution from the Wyatt transaction covering the first four-and-a-half months of the year has added 1.3% to full-year reported sales. The resulting full-year 2024 reported sales growth is expected in the range of -0.8% to -0.2%.The Company is also raising its full-year 2024 non-GAAP EPS guidance to now be in the range of $11.67 to $11.87, which includes an estimated headwind of approximately 3% due to unfavorable foreign exchange."

User Image DonCorleone77 Posted - 2 weeks ago

$WAT Waters raises FY24 EPS view to $11.67-$11.87 from $11.55-$11.65 Consensus $11.60. Raises FY24 revenue view to down 0.2%-0.8% from down 0.5%-2%, consensus $2.91B. The company said, "The Company is raising its full-year 2024 sales guidance, and now expects organic constant currency sales growth to be in the range of -0.9% to -0.3%. Currency translation is expected to decrease full-year sales growth by 1.2%. M&A contribution from the Wyatt transaction covering the first four-and-a-half months of the year has added 1.3% to full-year reported sales. The resulting full-year 2024 reported sales growth is expected in the range of -0.8% to -0.2%.The Company is also raising its full-year 2024 non-GAAP EPS guidance to now be in the range of $11.67 to $11.87, which includes an estimated headwind of approximately 3% due to unfavorable foreign exchange."

User Image DonCorleone77 Posted - 2 weeks ago

$WAT Waters sees Q4 EPS $3.90-$4.10, consensus $4.09 Sees Q4 revenue up 5%-7%, consensus $853.27M. The company said, "The Company expects fourth quarter 2024 constant currency sales growth to be in the range of +5.0% to +7.0%. Currency translation is expected to decrease fourth quarter sales growth by 1.7%. The resulting fourth quarter 2024 reported sales growth is expected in the range of +3.3% to +5.3%. The Company expects fourth quarter 2024 non-GAAP EPS to be in the range of $3.90 to $4.10, which includes an estimated headwind of approximately 3% due to unfavorable foreign exchange."

User Image Elfy Posted - 2 weeks ago

$WAT flying pre-market

User Image DonCorleone77 Posted - 2 weeks ago

$WAT Waters reports Q3 EPS $2.93, consensus $2.68 Reports Q3 revenue $740.31M, consensus $713.02M. "We delivered exceptional third quarter results, fueled by new product adoption and improved customer spending trends," said Udit Batra, president and CEO, Waters Corporation. "Instruments returned to growth sooner than expected, as liquid chromatography sales to pharma and industrial customers turned positive."

User Image JFDI Posted - 10/30/24

The reality is, ...if you're not treating this like a video $GME You're letting the sheep win the $DUOL. As the Lord stated, rise of the degen's YA $RDDT or $WAT

User Image ChessGM Posted - 10/26/24

$WAT Upcoming Earnings Alert for 10/29/2024 Consensus Signal: Bullish (8.0) Waters Corporation has been making significant strides in its product offerings, particularly with the introduction of new bioseparations tools that enhance the development of RNA-based vaccines and therapies. This innovation aligns with the current demand for advanced technologies in the biopharmaceutical sector, showcasing Waters' commitment to supporting the development of crucial health solutions. Furthermore, the launch of the Discovery Core Rheometer indicates the company's focus on expanding its portfolio to cater to diverse industries, including manufacturing and quality control. Additionally, the scheduled Q3 2024 earnings conference call reflects the company's transparency and proactive approach in communicating financial performance. Overall, these developments suggest a positive outlook for Waters Corporation, driven by strong product innovation and market demand. Waters Corporation's upcoming earnings conference call is set for November 1st, 2024, at 8:00 a.m. Eastern Time. This call will provide insights into the company's financial performance for the third quarter of 2024 and is expected to attract attention from analysts and investors alike. A live webcast will be available on the Waters Investor Relations website, with a replay accessible until November 29th, 2024. The anticipation surrounding the earnings report may lead to increased interest in the stock, particularly as investors look for indications of growth and performance metrics in the current fiscal environment. Statistics: 6 news articles from 5 unique news sources. - Funds were net buyers of $WAT during the previous reporting quarter. - Top 5 funds with large holdings in $WAT: * FundSmith LLP $1,060MM (Market Value). CGMFundScore: 77% * Generation Investment Management LLP $526MM (Market Value). CGMFundScore: 74% * AKO Capital LLP $255MM (Market Value). CGMFundScore: 89% * Baillie Gifford & Co Ltd $14MM (Market Value). CGMFundScore: 81% * The Investment House LLC $4MM (Market Value). CGMFundScore: 86% - Last 10 days performance: -9% - Last 30 days performance: -4% - Last 90 days performance: 3% Follow ChessGM! Do not miss other earnings alerts from ChessGM. Not a financial advice.

User Image Himel92 Posted - 1 month ago

The Last month Performance for $WAT Opening Price: $329.61 Closing Price: $347.31 Highest Price: $364.60 Lowest Price: $327.55 Percentage Change: 5.37% Data provider: AITX

User Image JFDI Posted - 1 month ago

@Wigglyick all over $WAT

User Image WeeklyTrader Posted - 1 month ago

Join the discussion about $WAT's rise! RSI: 61.23% 50-day MA: $340.11 200-day MA: $325.92

User Image Wigglyick Posted - 1 month ago

$WAT Waters Corp. Will it continue to follow the script or breakout ?

User Image WeeklyTrader Posted - 1 month ago

Let’s dive into the bearish trends for $WAT!

User Image Wigglyick Posted - 1 month ago

@Doozio other instrumentation companies good too $WAT $MKSI $TRMB

User Image WeeklyTrader Posted - 1 month ago

Time to rethink $WAT!

Analyst Ratings
Evercore ISI Group In-Line Oct 1, 24
Wells Fargo Overweight Aug 27, 24
TD Cowen Hold Aug 1, 24
Barclays Underweight Aug 1, 24
Deutsche Bank Hold Aug 1, 24
Leerink Partners Outperform Aug 1, 24
Evercore ISI Group In-Line Jul 2, 24
Barclays Underweight Jun 28, 24
Barclays Underweight May 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
KUEBLER CHRISTOPHER A Director Director Aug 04 Sell 291.48 4,000 1,165,920 14,382 08/07/23
KUEBLER CHRISTOPHER A Director Director Aug 04 Option 99.22 4,000 396,880 18,382 08/07/23
CONARD EDWARD Director Director Nov 30 Option 335.42 4,000 1,341,680 75,283 12/01/22
CONARD EDWARD Director Director Nov 30 Sell 334.7 1,059 354,447 74,224 12/01/22
KUEBLER CHRISTOPHER A Director Director May 19 Option 88.71 4,000 354,840 18,064 05/23/22
KUEBLER CHRISTOPHER A Director Director May 19 Sell 328.78 4,000 1,315,120 14,064 05/23/22
Hendrickson Gary E Director Director May 05 Sell 335.74 5,962 2,001,682 2,283 05/09/22
Hendrickson Gary E Director Director May 05 Option 335.69 5,962 2,001,384 8,245 05/09/22
BADDOUR LINDA Director Director Aug 17 Sell 408.99 1,260 515,327 1,797 08/17/21
BADDOUR LINDA Director Director Aug 17 Option 183.41 1,260 231,097 3,057 08/17/21
Buck Sherry SVP and CFO SVP and CFO Nov 02 Option 141.74 17,499 2,480,308 21,219 11/02/20
Buck Sherry SVP and CFO SVP and CFO Nov 02 Sell 221.62 17,499 3,878,128 3,720 11/02/20